FindTrial
Sign In

Red light in skin healing of cancer patients

Physiotherapeutic Approach to the complications of Oncological Treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7zsggy2
Enrollment
Unknown
Registered
2024-03-02
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiodermatitis

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. Patients diagnosed with radiodermatitis will be divided into two groups. Experimental group: 40 patients will receive treatment w
E02.594.540

Sponsors

Universidade Federal de Santa Maria
Lead Sponsor
Universidade Federal de Santa Maria
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals of both sexes; cancer and ending with radiotherapy; I tend to develop radiodermite in any gray

Exclusion criteria

Exclusion criteria: Minors under 18 years of age; metastase na pele; concomitant chemotherapy; infection in the region to be treated; história de doenças de pele ou autoimmunes; history of photosensitivity; inability to answer questions

Design outcomes

Primary

MeasureTime frame
It is expected that the intervention group will have a faster recovery from damaged skin due to radiodermite, when compared to the control group. The degree of radiodermite will be evaluated by the Radiation Therapy Oncology Group scale—

Secondary

MeasureTime frame
Expect to promote better quality of life specific dermatologically endorsed questionnaire Skindex-16—

Countries

Brazil

Contacts

Public ContactHedioneia Pivetta

Universidade Federal de Santa Maria

hedioneia@yahoo.com.br+55-55-999716183

Outcome results

None listed

Source: REBEC (via WHO ICTRP)